Ophthalmic Artery Chemosurgery for Retinoblastoma Prevents New Intraocular Tumors

Objective: To determine the incidence and timing of new intraocular tumor foci in genetic retinoblastoma cases after treatment with ophthalmic artery chemosurgery (OAC). Design: Single-center retrospective review of all genetic retinoblastoma cases managed at Memorial Sloan-Kettering Cancer Center/Weil-Cornell Medical School since May 2006. Participants: Eighty-one patients (80 with bilateral disease and 1 with unilateral disease with a family history) with genetic retinoblastoma, with a total of 116 eyes treated with OAC since May 2006. Methods: Retrospective, single-institution review of patients with bilateral retinoblastoma and unilateral retinoblastoma with a positive family (Read more...)

Full Story →